We advise you to exercise Vimta Labs fundamental analysis to see if markets are presently mispricing the corporation. In other words this interface allows you to confirm available indicators of Vimta Labs Limited as well as the relationship between them. . We found twenty-six available drivers for Vimta Labs Limited which can be compared to its competition. To make sure the equity is not overpriced, please validate all Vimta Labs fundamentals including its Total Debt, and the relationship between EBITDA and Earnings Per Share . Use Vimta Labs to protect your portfolios against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Vimta Labs to be traded at 295.15 in 30 days.
Vimta Labs Company Summary
Vimta Labs competes with Medinova Diagnostic, Vakrangee, Walchand Peoplefirst, Dhampur Sugar, and Dabur India. Vimta Labs Limited provides contract research and testing services in India and internationally. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India. Vimta Labs operates under Diagnostics Research classification in India and is traded on Bombay Stock Exchange. It employs 1081 people.
Vimta Labs Limited is rated first in z score category among related companies. It is rated first in cash and equivalents category among related companies creating about 2,414,912 of Cash and Equivalents per Z Score.
Vimta Labs Market Fundamentals
Vimta Labs Financial Distress Probability
Chance of Financial Distress
Vimta Labs Limited has less than 26 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info